PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Going out on a limb here...

With CRO’s there are different organizational and operational differences.

KW stated:
“We are extremely grateful to those prominent oncologists who have agreed to join our Oncology Advisory Board to assist ”us” in finalizing our clinical trial protocol and in sharing their views on how best to achieve our goal of making our therapy available to those patients who desperately need an effective treatment for LAPC. We received invaluable input from these experts in pancreatic cancer that should allow PharmaCyte to enter the clinic with the best possibility for success.”

Who could “us” be?

If you’re having such a meeting, you’re probably working to align your new CRO’s protocols, processes, and procedures with the FDA requirements.

Go PharmaCyte!!! :) :) :)